Publication:
Risk factors of isoniazid mono-resistance among pulmonary tuberculosis patients at central chest institute of Thailand

dc.contributor.authorPhenlak Kaewthongen_US
dc.contributor.authorPramote Tragulpiankiten_US
dc.contributor.authorChareon Chuchottawornen_US
dc.contributor.authorSukanya Wattanapokayakiten_US
dc.contributor.authorSuppanut Prakongsupen_US
dc.contributor.authorNuanjun Wichukchindaen_US
dc.contributor.authorSurakameth Mahasirimongkolen_US
dc.contributor.otherThailand Ministry of Public Healthen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherCentral Chest Institute of Thailanden_US
dc.date.accessioned2020-08-25T10:31:44Z
dc.date.available2020-08-25T10:31:44Z
dc.date.issued2020-07-01en_US
dc.description.abstract© 2020, Mahidol University - Faculty of Pharmacy. Risk factors of isoniazid mono-resistance were reported by N-acetyltransferase 2 (NAT2) gene and some clinical factors in the literature. This study aimed to determine the risk factors of isoniazid mono-resistance among Thai pulmonary tuberculosis patients. The case-control study was conducted from 18th September 2017 to 20th February 2018. Demographic data were collected from medical record review and interview. NAT2 genotypes were collected from saliva samples collection and determined by multiplex polymerase chain reaction and gel electropherosis. Risk factors were conducted by multivariate logistic regression analysis and strength of association was reported as odd ratio with 95% confident interval. Total 167 participants comprised of 50 isoniazid mono-resistant and 117 drug-susceptible tuberculosis patients. NAT24/6A was the most common genotype in both 12 (24.0%) cases and 38 (32.5%) controls, respectively, and there was not significantly different among genotypes between two groups (p-value = 0.352). Moreover, rapid acetylator was not significantly associated with isoniazid mono-resistance compared with slow acetylator (OR 1.169; 95%CI 0.435-3.140, p-value = 0.389). Adults who were less than 50 years old were more likely to develop isoniazid mono-resistance (adjusted OR 2.281; 95%CI 1.101-4.728, p-value = 0.027) than elderlys who were older than 50 years old. In contrast, ever-drinkers were less likely to develop isoniazid mono-resistance (adjusted OR 0.417; 95%CI 0.207-0.842, p-value = 0.015). In conclusion, the young adults and never-drinkers are risk factors of isoniazid mono-resistance in these Thai pulmonary tuberculosis patients. Moreover, a further study is needed to clarify the role of NAT2 on isoniazid mono-resistance in Thais.en_US
dc.identifier.citationPharmaceutical Sciences Asia. Vol.47, No.3 (2020), 226-237en_US
dc.identifier.doi10.29090/psa.2020.03.019.0069en_US
dc.identifier.issn25868470en_US
dc.identifier.issn25868195en_US
dc.identifier.other2-s2.0-85088708774en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/58093
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088708774&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleRisk factors of isoniazid mono-resistance among pulmonary tuberculosis patients at central chest institute of Thailanden_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088708774&origin=inwarden_US

Files

Collections